©copyright CANCAN DIAGNOSTICS. All right reserved 2023.
Designed by
Menu
we care about your pets
Cancer is one of the leading causes of death in dogs, with between 30-50% of animals developing it in their lifetime. We developed a cell-free DNA next generation sequencing-based liquid biopsy panel for screening, early diagnosis and monitoring of canine cancer.
WE CARE ABOUT YOUR HELP
THE RESEARCH
Screening &
Detection.
We are developing a test for screening, early detection and monitoring of cancer in dogs. The project is based on detection of cancer-related mutations in cell-free DNA, which is isolated from dog’s plasma. Cell-free DNA are DNA fragments that are released to blood when cells die. The isolated DNA is then sequenced using a custom-build next-generation sequencing enrichment panel and state-of-the-art analysis pipeline.
THE RESEARCH
Screening &
Detection.
We are developing a test for screening, early detection and monitoring of cancer in dogs. The project is based on detection of cancer-related mutations in cell-free DNA, which is isolated from dog’s plasma. Cell-free DNA are DNA fragments that are released to blood when cells die. The isolated DNA is then sequenced using a custom-build next-generation sequencing enrichment panel and state-of-the-art analysis pipeline.
HOW WE CAN HELP
HOW WE CAN HELP
The assay being developed can revolutionise how we screen for, diagnose and monitor cancer. The only thing that you need is a routine, minimally invasive blood draw. No sedation or anaesthesia is needed in the majority of animals. Earlier diagnosis allows for earlier treatment and potentially better outcomes!
©copyright CANCAN DIAGNOSTICS. All right reserved 2023.
Designed by